Sentry 340B BI is fully customizable and accessible, designed to help users yield powerful insights
 
May 19, 2021— Sentry Data Systems, Inc., the nation’s leader in pharmacy procurement, compliance and utilization management, today introduced the 340B BI tool as a breakthrough for customers who need more transparency from their data to counter increased complexity in their 340B programs. Sentry 340B BI seamlessly integrates with its customers’ continuously updated data — including ordering platforms — and is designed to allow even non-experts to run advanced business intelligence reports.
 
“Sentry 340B BI changes the game by providing easy access to sophisticated, robust data sets, dashboards and reporting that uncover valuable insights to help covered entities maximize their benefits,” said Travis Leonardi, RPh, founder and CEO of Sentry Data Systems. “By being fully customizable and easy to use, our new solution goes beyond anything offered by our competitors and represents the next level in analytics reporting for our customers.”
 
Sentry 340B BI aggregates customers’ data and populates it into an easy-to-use analytics and reporting environment. It’s a highly flexible, advanced solution designed to be readily accessible, with drag-and-drop functionality – without the need to enlist a consultant or analyst to write queries or build reports. The result is a robust visualization of a customer’s 340B program.
 
The tool is designed to integrate seamlessly with Sentry’s 340B platform, with the abilities to roll up numbers from mixed-use and contract pharmacy settings, and easily compare pharmacy data at an enterprise level. It allows for nearly limitless manipulation of information, with the ability to search and arrange data by drug manufacturer, NDC number and location, among other fields, to yield metrics on key concerns such as drug spending, claims volume, dispensations and revenue.
 
For covered entities, the new 340B BI tool has powerful applications for managing audits, changes from drug manufacturers, vertical integration and hospital consolidation.
 
 
 
About Sentry Data Systems, Inc.
Sentry Data Systems, Inc. is a pioneer in providing technology solutions that help healthcare providers address their three biggest challenges: reducing total cost of care, managing compliance and producing better quality. Thousands of hospitals and care locations across the country rely on Sentry’s integrated platform for their solutions, which provide decision support for millions of unique patients and have helped hospital systems and IDNs realize billions of dollars in documented savings.
 
 
 
 


May 19, 2021 – When it comes to dementia caregiving, planning ahead can seem a daunting task. In the hopes of making it easier, on May 25, the Alzheimer’s Association will present “The Proactive Path,” a virtual program to address how to prepare for the future while caring for a loved one with Alzheimer’s disease or another dementia.
 
The program, as part of the Alzheimer’s Association’s ongoing “Ask the Expert” series, will offer helpful insight into such topics as legal and financial planning, identifying a care team and navigating the overall caregiving experience.
 
“For those facing Alzheimer’s and other dementias, the benefits of planning ahead are immeasurable,” said Amy Schenk, program manager for the Alzheimer’s Association. “When a loved one reaches the stage where they can no longer make decisions on their own, it can provide caregivers with such peace of mind knowing that they already have a plan in place. With this program, we aim to guide caregivers through the planning process with helpful advice from experts in the field.”
 
Featured guest speakers will include Jason Penrod, elder law attorney and founder of Family Elder Law; Cynthia Perthuis, area owner of Senior Care Authority; and Sue Ryan, author of “Our Journey of Love: 5 Steps to Navigate Your Caregiving Journey.”
The free program will begin at 1 p.m. EDT on Tuesday, May 25. Register by calling the Alzheimer’s Association 24/7 Helpline at (800) 272-3900 or by visiting http://bit.ly/ProactivePath. 
 
To learn more about additional free programming from the Alzheimer’s Association, visit www.alz.org. 
 
 
 
Alzheimer’s Association®
The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer’s and all other dementia – by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer’s and all other dementia. Visit alz.org or call (800) 272-3900.


PRESENTED BY HEALTHCARE LAW PARTNERS, LLC



May 18, 2021 – Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.4 billion in aggregate principal amount of newly issued senior secured first lien notes maturing in 2029 (the “notes”). Completion of the offering is subject to, among other things, pricing and standard closing and market conditions.
 
Tenet intends to use the net proceeds from the sale of the notes, after payment of fees and expenses, to finance, together with cash on hand, the redemption of all of its outstanding 5.125% senior secured second lien notes due 2025 (the “2025 second lien notes”).
 
The notes will be guaranteed by certain of Tenet’s subsidiaries and secured on a first lien priority basis by a pledge of the capital stock and other ownership interests of certain of Tenet’s subsidiaries. The notes will be effectively senior to Tenet’s existing and future indebtedness secured on a more junior basis, as well as unsecured indebtedness and other liabilities, to the extent of the value of the collateral securing such borrowings.
 
The notes to be offered will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or any other state securities laws. As a result, they may not be offered or sold in the United States or to any U.S. persons, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the notes will be offered only to persons reasonably believed to be “qualified institutional buyers” under Rule 144A of the Securities Act or, outside the United States, to persons other than “U.S. persons” in compliance with Regulation S under the Securities Act. A confidential offering memorandum for the notes will be made available to such eligible persons. The offering will be conducted in accordance with the terms and subject to the conditions set forth in such offering memorandum.
 
This news release is neither an offer to sell nor a solicitation of an offer to buy, nor shall there be any sale of, these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. This news release shall not constitute a notice of redemption of the 2025 second lien notes.
 
Cautionary Statement
 
This release contains “forward-looking statements” – that is, statements that relate to future, not past, events. In this context, forward-looking statements often address the Company’s expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “assume,” “believe,” “budget,” “estimate,” “forecast,” “intend,” “plan,” “predict,” “project,” “seek,” “see,” “target,” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Particular uncertainties that could cause the Company’s actual results to be materially different than those expressed in the Company’s forward-looking statements include, but are not limited to, the factors disclosed under “Forward-Looking Statements” and “Risk Factors” in our Form 10-K for the year ended December 31, 2020, any subsequent Form 10-Q filings and other filings with the Securities and Exchange Commission.
 
About Tenet Healthcare
 
Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas with 108,000 employees. Through an expansive care network that includes United Surgical Partners International, we operate 65 hospitals and approximately 450 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, imaging centers and other care sites and clinics. We also operate Conifer Health Solutions, which provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve.


The advanced technology plays a pivotal role in the award-winning hospital’s successful treatment of uterine, ovarian, cervical and vulvar cancers, as well as other complicated gynecologic medical issues. 
 
May 18 2021 – Dr. Donna M. Pinelli, Medical Director of Gynecologic Oncology at Jupiter Medical Center’s Anderson Family Cancer Institute and the Frank E. and Mary D. Walsh Robotic Surgery Program at Jupiter Medical Center, performed her 2,000th surgery using the revolutionary da Vinci® Xi Robotic Surgical System.
 
The da Vinci® Robotic Surgical System provides surgical assistance beyond the capabilities of human hands; increases the surgeon’s view using high-definition 3-D visualization; and is used in a number of areas including gynecologic, thoracic, gastrointestinal, pancreatic, HIPEC, urologic, and general surgeries.
 
“Employing the most sophisticated technologies in the hands of physician experts is at the forefront of our mission to provide the best possible care for our community,” says Amit Rastogi, MD, MHCM, CEO of Jupiter Medical Center. “Dr. Pinelli’s 2,000th da Vinci® robotic surgery is an indicating milestone of Jupiter Medical Center bringing the most advanced technologies and innovative procedures to our patients.”
 
Board certified and fellowshipped trained, Dr. Pinelli’s clinical expertise includes specializing in radical pelvic surgery for treating uterine, ovarian, cervical and vulvar malignancies; risk-reducing surgeries; and other innovative approaches to treating gynecologic cancers.
 
Dr. Pinelli’s role is a critical part of the comprehensive care provided by the team of multidisciplinary experts at the Anderson Family Cancer Institute at Jupiter Medical Center. Our multidisciplinary team includes surgical oncologists, medical oncologists, radiation oncologists, diagnostic and interventional radiologists, pathologists, nurses, therapists and allied health professionals with specialized training in cancer care who are committed to providing cancer care of the highest quality.
 
The Walsh Robotic Surgery Program recently celebrated its 10th Anniversary with the addition of a third Xi robotic surgery system with the latest fourth generation technology. The latest generation system expands upon core da Vinci system features and offers surgeons: the 3D-HD vision system, virtually extending the surgeon’s eyes and hands into the patient; instrument arm architecture providing the surgeon with anatomical access from virtually any position; and smaller, thinner arms with newly designed joints that offer a greater range of motion than ever before.
 
Jupiter Medical Center
 
Rated No. 1 for safety, quality and patient satisfaction, Jupiter Medical Center is the leading destination for world-class health care in Palm Beach County and across the Treasure Coast. The award-winning hospital is iconic throughout the state because of its outstanding team of physicians, state-of-the-art facilities, innovative techniques and technologies and commitment to compassionate care.  Jupiter Medical Center is recognized as the region’s only independent, not-for-profit hospital providing an array of inpatient and outpatient services, including Heart and Vascular Healthcare, Oncology, Orthopedics and Women & Children’s Healthcare Services. For more information about Jupiter Medical Center, please call (561) 263-2234 or visit www.jupitermed.com.